{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:56:56Z","timestamp":1648627016262},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00108-006-1624-9","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T05:51:22Z","timestamp":1146635482000},"page":"568-577","source":"Crossref","is-referenced-by-count":3,"title":["Funktionelle Dyspepsie \u2013 eine Verlegenheitsdiagnose?"],"prefix":"10.1007","volume":"47","author":[{"given":"T.","family":"Liebregts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1624_CR1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/003655201750305440","volume":"36","author":"Allescher","year":"2001","unstructured":"Allescher HD, Bockenhoff A, Knapp G et al. (2001) Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 36: 934\u2013941","journal-title":"Scand J Gastroenterol"},{"key":"1624_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/gut.46.1.93","volume":"46","author":"Breslin","year":"2000","unstructured":"Breslin NP, Thomson AB, Bailey RJ et al. (2000) Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 46: 93\u201397","journal-title":"Gut"},{"key":"1624_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004836-198904000-00011","volume":"11","author":"Dobrilla","year":"1989","unstructured":"Dobrilla G, Comberlato M, Steele A et al. (1989) Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 11: 169\u2013177","journal-title":"J Clin Gastroenterol"},{"key":"1624_CR4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38: 1569\u20131580","journal-title":"Dig Dis Sci"},{"key":"1624_CR5","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/j.1572-0241.1999.2329a.x","volume":"94","author":"Gillen","year":"1999","unstructured":"Gillen D, McColl KE (1999) Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 94: 2329\u20132330","journal-title":"Am J Gastroenterol"},{"key":"1624_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/00365529309098293","volume":"28","author":"Gudjonsson","year":"1993","unstructured":"Gudjonsson H, Oddsson E, Bjornsson S et al. (1993) Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study. Scand J Gastroenterol 28: 969\u2013972","journal-title":"Scand J Gastroenterol"},{"key":"1624_CR7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/00365529008997630","volume":"25","author":"Hausken","year":"1990","unstructured":"Hausken T, Stene-Larsen G, Lange O et al. (1990) Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study. Scand J Gastroenterol 25: 1028\u20131033","journal-title":"Scand J Gastroenterol"},{"key":"1624_CR8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1046\/j.1365-2036.2003.01767.x","volume":"18","author":"Holtmann","year":"2003","unstructured":"Holtmann G, Adam B, Haag S et al. (2003) Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 18: 1099\u20131105","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.42.4.501","volume":"42","author":"Holtmann","year":"1998","unstructured":"Holtmann G, Goebell H, Jockenhoevel F (1998) Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 42: 501\u2013506","journal-title":"Gut"},{"key":"1624_CR10","first-page":"485","volume":"91","author":"Holtmann","year":"1996","unstructured":"Holtmann G, Goebell H, Talley NJ (1996) Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 91: 485\u2013491","journal-title":"Am J Gastroenterol"},{"key":"1624_CR11","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.1999.00644.x","volume":"13","author":"Holtmann","year":"1999","unstructured":"Holtmann G, Gschossmann J, Karaus M (1999) Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 13: 1459\u20131465","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1046\/j.1365-2036.2002.01322.x","volume":"16","author":"Holtmann","year":"2002","unstructured":"Holtmann G, Gschossmann J, Mayr P et al. (2002) A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 16: 1641\u20131648","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/gut.47.3.332","volume":"47","author":"Holtmann","year":"2000","unstructured":"Holtmann G, Gschossmann J, Neufang-Huber J et al. (2000) Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut 47: 332\u2013336","journal-title":"Gut"},{"key":"1624_CR14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/gast.2002.36556","volume":"123","author":"Holtmann","year":"2002","unstructured":"Holtmann G, Gschossmann JM, Buenger L et al. (2002) Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 123: 1451\u20131458","journal-title":"Gastroenterology"},{"key":"1624_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1078\/1433-187X-00310","volume":"10","author":"Holtmann","year":"2003","unstructured":"Holtmann G, Haag S, Adam B et al. (2003) Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia. Phytomedicine 10 [Suppl 4]: 56\u201357","journal-title":"Phytomedicine"},{"key":"1624_CR16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1023\/B:DDAS.0000026317.00071.75","volume":"49","author":"Holtmann","year":"2004","unstructured":"Holtmann G, Kutscher SU, Haag S et al. (2004) Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study. Dig Dis Sci 49: 672\u2013679","journal-title":"Dig Dis Sci"},{"key":"1624_CR17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","volume":"126","author":"Holtmann","year":"2004","unstructured":"Holtmann G, Siffert W, Haag S et al. (2004) G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 126: 971\u2013979","journal-title":"Gastroenterology"},{"key":"1624_CR18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T et al. (2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354: 832\u2013840","journal-title":"N Engl J Med"},{"key":"1624_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1997.00179.x","volume":"11","author":"Jones","year":"1997","unstructured":"Jones RH, Baxter G (1997) Lansoprazole 30\u00a0mg daily versus ranitidine 150\u00a0mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 11: 541\u2013546","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9343(87)90828-X","volume":"83","author":"Kairaluoma","year":"1987","unstructured":"Kairaluoma MI, Hentilae R, Alavaikko M et al. (1987) Sucralfate versus placebo in treatment of non-ulcer dyspepsia. Am J Med 83: 51\u201355","journal-title":"Am J Med"},{"key":"1624_CR21","doi-asserted-by":"crossref","first-page":"G776","DOI":"10.1152\/ajpgi.00456.2002","volume":"284","author":"Kamerling","year":"2003","unstructured":"Kamerling IM, Van Haarst AD, Burggraaf J et al. (2003) Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers. Am J Physiol Gastrointest Liver Physiol 284: G776-G781","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1624_CR22","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1440-1746.2005.04163.x","volume":"20","author":"Liebregts","year":"2005","unstructured":"Liebregts T, Adam B, Holtmann G (2005) Susceptibility genes and functional gastrointestinal disorders. J Gastroenterol Hepatol 20: 1792\u20131793","journal-title":"J Gastroenterol Hepatol"},{"key":"1624_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-2001-18536","volume":"39","author":"Malfertheiner","year":"2001","unstructured":"Malfertheiner P, Holtmann G, Peitz U (2001) Guidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsia. Z Gastroenterol 39: 937\u2013956","journal-title":"Z Gastroenterol"},{"key":"1624_CR24","first-page":"1149","volume":"46","author":"May","year":"1996","unstructured":"May B, Kuntz HD, Kieser M et al. (1996) Efficacy of a fixed peppermint oil\/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung 46: 1149\u20131153","journal-title":"Arzneimittelforschung"},{"key":"1624_CR25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","volume":"339","author":"McColl","year":"1998","unstructured":"McColl K, Murray L, el Omar E (1998) Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339: 1869\u20131874","journal-title":"N Engl J Med"},{"key":"1624_CR26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/gut.40.3.302","volume":"40","author":"McColl","year":"1997","unstructured":"McColl KE, El Nujumi A, Murray L et al. (1997) The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 40: 302\u2013306","journal-title":"Gut"},{"key":"1624_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1572-0241.1999.00781.x","volume":"94","author":"Mearin","year":"1999","unstructured":"Mearin F, Balboa A, Zarate N et al. (1999) Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 94:116\u2013125","journal-title":"Am J Gastroenterol"},{"key":"1624_CR28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"Melzer","year":"2004","unstructured":"Melzer J, Rosch W, Reichling J (2004) Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 20: 1279\u20131287","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A et al. (1998) Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93: 160\u2013165","journal-title":"Am J Gastroenterol"},{"key":"1624_CR30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","volume":"355","author":"Moayyedi","year":"2000","unstructured":"Moayyedi P, Feltbower R, Brown J et al. (2000) Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet 355: 1665\u20131669","journal-title":"Lancet"},{"key":"1624_CR31","unstructured":"Moayyedi P, Soo S, Deeks J et al. (2004) Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev CD001960"},{"key":"1624_CR32","doi-asserted-by":"crossref","unstructured":"Nyren O, Adami HO, Bates S et al. (1986) Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 314 339\u2013343","DOI":"10.1056\/NEJM198602063140603"},{"key":"1624_CR33","first-page":"1007","volume":"89","author":"Pazzi","year":"1994","unstructured":"Pazzi P, Gamberini S, Scagliarini R et al. (1994) Misoprostol for the treatment of chronic erosive gastritis: a double-blind placebo-controlled trial. Am J Gastroenterol 89: 1007\u20131013","journal-title":"Am J Gastroenterol"},{"key":"1624_CR34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.1996.v110.pm8536890","volume":"110","author":"Silverstein","year":"1996","unstructured":"Silverstein MD, Petterson T, Talley NJ (1996) Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 110: 72\u201383","journal-title":"Gastroenterology"},{"key":"1624_CR35","doi-asserted-by":"crossref","unstructured":"Soo S, Moayyedi P, Deeks J et al. (2001) Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev CD002301","DOI":"10.1002\/14651858.CD002301"},{"key":"1624_CR36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"Talley","year":"2000","unstructured":"Talley NJ, Verlinden M, Snape W et al. (2000) Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 14: 1653\u20131661","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","volume":"102","author":"Talley","year":"1992","unstructured":"Talley NJ, Zinsmeister AR, Schleck CD et al. (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102: 1259\u20131268","journal-title":"Gastroenterology"},{"key":"1624_CR38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","volume":"31","author":"Tanum","year":"1996","unstructured":"Tanum L, Malt UF (1996) A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 31: 318\u2013325","journal-title":"Scand J Gastroenterol"},{"key":"1624_CR39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1365-2036.2003.01646.x","volume":"17","author":"Thomson","year":"2003","unstructured":"Thomson AB, Barkun AN, Armstrong D et al. (2003) The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment \u2013 Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 17: 1481\u20131491","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR40","first-page":"278","volume":"50","author":"Wu","year":"2003","unstructured":"Wu CY, Chou LT, Chen HP et al. (2003) Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. Hepatogastroenterology 50: 278\u2013283","journal-title":"Hepatogastroenterology"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1624-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1624-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:36Z","timestamp":1558584696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1624-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}